News Release

Update on the United States of America Patent Issued for Tetrodin (HT)

Date: 1999/01/25

International Wex Technologies Inc.("IWT") is pleased to announce that the corporation has been notified by the Commissioner of Patents and Trademarks Office of the USA that Tetrodin(HT) has received a patent number on December 8, 1998.

The "Preamble" reads:
"United States Patent grants to the person(s)having title to this patent the right to exclude others from making, using, offering for sale, or selling the invention throughout the United States of America or importing the invention into the United States of America……."

IWT has developed a patented new product named Tetrodin(HT). Tetrodin(HT) is a non-narcotic pharmaceutical that has proven to be a safe and effective treatment for all opiate (heroin, opium, morphine, methadone, etc.) addictions. Tetrodin(HT) functions very well in both primary withdrawal treatment and abstinence maintenance (longer term use) of drug addiction.

For additional information on Tetrodin (HT), view the IWT website at http://www.wextech.ca or call Howard Milne at 604-683-8880 or 1-800-722-7549 .

Per: Donna Shum, Corporate Secretary